Pulmonary hypertension prognosis refers to the outcome of pulmonary hypertension, risk of complications, duration, probable outcome, recovery prospects, how long the recovery period can be, survival rates, death rates and other related outcomes.
As you know, primary pulmonary hypertension is a rare condition that causes just as primary hypertension are unknown. Secondary pulmonary hypertension has known causes such as cardian and extrathoraic conditions. Since the condition is very rare, it affects less than one percent of people in the United States. The disorder has 300 cases every year in America. There are some experts that indicate that the true incident of the condition remains unknown.
Pulmonary hypertension prognosis studies almost led doctors to conclude that the disorder was only for young women. This is because the greater number of incidence was in women between 21 to 40 years old. However, it is now known that it affects men and women of all ages from very young children to the elderly inclusive of racial and different ethnic background factors.
Pulmonary hypertension prognosis course of the disorder is believed that it begins with injury occurring to the andothelial cells a layer of cells lining small blood vessels found in the lungs. The reason of this injury occurs in the first place is unknown. The changes were then introduced by the influences of the injury the interaction between endothelial cells and smooth muscle cells in the vessel walls. This has the overall effect of narrowing the vessels. Many doctors believe that this interactions leads to the development of additional amounts of tissue in the walls of the pulmonary arteries.
According to pulmonary hypertension prognosis, the median duration of survival after diagnosis is just under 3 years. However, this figure varies quite significantly. Since treatments are more advanced today, patients which do not have right ventricle dysfunction can even survive for up to 10 years with effective pulmonary hypertension treatment.